Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.

Zhao, Huihui; Xie, Rongrong; Zhang, Chenxi; Lu, Guojun; Kong, Hui

Zhao, Huihui; Xie, Rongrong; Zhang, Chenxi; Lu, Guojun; Kong, Hui.

Afiliación

Zhao H; Department of Oncology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
Xie R; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhang C; Central Laboratory, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Lu G; Department of Respiratory Medicine, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Kong H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Front Genet ; 13: 989460, 2022.

Article en En | MEDLINE | ID: mdl-36159971

Palabras clave

DTYMK; TCGA; immune infiltrates; immunotherapy; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Genet Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google